Skip to main content
. 2025 Apr 23;17(9):1401. doi: 10.3390/cancers17091401
AI Artificial Intelligence
AR Augmented Reality
AUC Area Under Curve
BCR Biochemical Recurrence
BCR-FS Biochemical Recurrence-Free Survival
cBR Complete Biochemical Response
CI Confidence Interval
CIM Conventional Imaging Modality
CT Computed Tomography
DRS Diffuse Reflectance Spectroscopy
ECE Extra-Capsular Extension
ePLND Extended Pelvic Lymph Node Dissection
HA3D Hyper Accuracy Three-Dimensional
HR Hazard Ratio
ICG Indocyanine Green
IFS Intraoperative Frozen Section
[111In]In-PSMA-I&T 111Indium-PSMA Imaging and Therapy
LNM Lymph Node Metastasis
LNI Lymph Node Invasion
MFS Metastasis-Free Survival
mpMRI Multiparametric Magnetic Resonance Imaging
NPV Negative Predictive Value
NSS Nerve Sparing Surgery
NVB Neuro Vascular Bundle
OR Odds Ratio
OS Overall Survival
PCa Prostate Cancer
PET Positron Emission Tomography
PPV Positive Predictive Value
PSA Prostate Specific Antigen
PSM Positive Surgical Margin
PSMA Prostate-Specific Membrane Antigen
RARP Robot-Assisted Radical Prostatectomy
RGS Radioguided Surgery
RP Radical Prostatectomy
RT Radiotherapy
sLND Salvage Lymph Node Dissection
SNB Sentinel Node Biopsy
SUVmax Standardized Uptake Value Maximum
SVI Seminal Vesicle Invasion
[99mTc]Tc-PSMA-I&S 99mTechnetium-PSMA Imaging and Surgery
TFS Treatment-Free Survival
TtB Target-to-Background
2D Two-Dimensional
3D Three-Dimensional